GBS Says Awarded $4.7M Australian Federal Government Science Grant To Manufacture Biosensor Technology
GBS (NASDAQ:GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point-of-care, today announced it has been awarded a USD $4.7